Selective internal radiation therapy-induced extrahepatic injury an emerging cause of iatrogenic organ damage

American Journal of Surgical Pathology

Volumn 33, Issue 7, 2009, Pages 963-975

  Crowder, Clinton D ^a,b   Grabowski, Carol ^c   Inampudi, Subbarao ^d   Sielaff, Timothy ^e   Sherman, Cynthia A ^f   Batts, Kenneth P ^a,b,f,g  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b The Departments of Pathology   (United States)

^c Departments of Radiation Oncology   (India)

^d Departments of Radiology

^e Virginia Piper Cancer Institute   (United States)

^f Minnesota Gastroenterology PA   (United States)

^g ABBOTT NORTHWESTERN HOSPITAL   (United States)

Author keywords

Hepatic metastases; Internal radiation therapy; Microsphere; SIRT; Yttrium

Indexed keywords

MICROSPHERE; YTTRIUM 90;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; CHOLECYSTITIS; COLORECTAL CANCER; FEMALE; GASTRITIS; HEPATIC ARTERY; HUMAN; HUMAN TISSUE; IATROGENIC DISEASE; INJECTION; LIVER METASTASIS; LIVER TUMOR; MALE; RADIATION INJURY; SELECTIVE INTERNAL RADIATION THERAPY; TISSUE INJURY; TREATMENT OUTCOME;

AGED; BRACHYTHERAPY; CHOLECYSTITIS; FEMALE; GASTRITIS; HUMANS; LIVER NEOPLASMS; MALE; MICROSPHERES; MIDDLE AGED; RADIATION INJURIES; YTTRIUM RADIOISOTOPES;

EID: 67649516206     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31817ed787     Document Type: Article

References (81)

1. Meta-Analysis Group in Cancer. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst. 1996;88:252-258.
2. Adam R, Akpinar E, Johann M, et al. Place of cryosurgery in the treatment of malignant liver tumors. Ann Surg. 1997;225:39-48; discussion 48-50.
3. Anderson JH, Goldberg JA, Bessent RG, et al. Glass yttrium-90 microspheres for patients with colorectal liver metastases. Radiother Oncol. 1992;25:137-139.
4. Andrews J, Walker S, Ackermann R, et al. Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up. J Nucl Med. 1994;35:1637-1644.
5. Ariel IM. Treatment of inoperable primary pancreatic and liver cancer by the intra-arterial administration of radioactive isotopes (Y90 radiating microspheres). Ann Surg. 1965;162:267-278.
6. Ariel IM, Pack GT. Treatment of inoperable cancer of the liver by intra-arterial radioactive isotopes and chemotherapy. Cancer. 1967; 20:793-804.
7. Ariel IM, Padula G. Treatment of symptomatic metastatic cancer to the liver from primary colon and rectal cancer by the intraarterial administration of chemotherapy and radioactive isotopes. J Surg Oncol. 1978;10:327-336.
8. Ariel IM, Padula G. Treatment of asymptomatic metastatic cancer to the liver from primary colon and rectal cancer by the intraarterial administration of chemotherapy and radioactive isotopes. J Surg Oncol. 1982;20:151-156.
9. Arulampalam TH, Costa DC, Loizidou M, et al. Positron emission tomography and colorectal cancer. Br J Surg. 2001;88:176-189.
10. Baxter PS, Wemyss-Holden SA, Dennison AR, et al. Electrochemically induced hepatic necrosis: the next step forward in patients with unresectable liver tumours? Aust N Z J Surg. 1998;68:637-640.
11. Bengtsson G, Carlsson G, Hafstrom L, et al. Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg. 1981;141:586-589.
12. Blanchard RJW. Treatment of liver tumors with yttrium-90 microspheres. Can J Surg. 1982;26:442-443.
13. Blanchard RJW, Morrow IM, Sutherland JB. Treatment of liver tumors with Yttrium-90 microspheres alone. J Can Assoc Radiol. 1989;40:206-210.
14. Burton MA, Gray BN, Klemp PF, et al. Selective internal radiation therapy: distribution of radiation in the liver. Eur J Cancer Clin Oncol. 1989;25:1487-1491.
15. Campbell AM, Bailey IH, Burton MA. Analysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy. Phys Med Biol. 2000;45:1023-1033.
16. Campbell AM, Bailey IH, Burton MA. Tumour dosimetry in human liver following hepatic yttrium-90 microsphere therapy. Phys Med Biol. 2001;46:487-498.
17. Cao X, Nengshu HE, Jianzhong SUN, et al. Hepatic radioembolization with Yttrium-90 glass microspheres for treatment of primary liver cancer. Chin Med J. 1999;112:430-432.
18. Carr BI. Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients. Liver Transplant. 2004;10: S107-S110.
19. Coldwell D, Kennedy A, Echo DV. Comparative side effects of yttrium-90 based intra-arterial brachytherapy. J Clin Oncol. 2004; 22:3760.
20. Dancey JE, Shepherd FA, Paul K, et al. Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres. J Nucl Med. 2000;41:1673-1681.
21. Dhabuwala A, Lamerton P, Stubbs RS. Relationshiop of 99mtechnetium labelled macroaggregated albumin (99mTc-MAA) uptake by colorectal liver metastases to response following selective internal radiation therapy (SIRT). BMC Nucl Med. 2005;5:7.
22. Fajardo LF, Colby TV. Pathogenesis of veno-occlusive liver disease after radiation. Arch Pathol Lab Med. 1980;104:584-588.
23. Fernandez FG, Drebin JA, Linehan DC, et al. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg. 2004;240:438-447; discussion 447-450.
24. Fong Y, Blumgart LH, Cohen AM. Surgical treatment of colorectal metastases to the liver. CA Cancer J Clin. 1995;45:50-62.
25. Fox RA, Klemp PF, Egan G, et al. Dose distribution following selective internal radiation therapy. Int J Radiat Oncol Biol Phys. 1991;21:463-467.
26. Geschwind JFH, Salem R, Carr BI, et al. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology. 2004;127:S194-S205.
27. Goin JE, Dancey JE, Hermann GA, et al. Treatment of unresectable metastatic colorectal carcinoma to the liver with intrahepatic Y-90 microspheres: dose-ranging study. World J Nucl Med. 2003;2: 216-225.
28. Goin JE, Salem R, Carr B, et al. Treatment of unresectable hepatocellular carcinoma with intrahepatic Yttrium 90 microspheres: a risk-stratification analysis. J Vasc Interv Radiol. 2005;16: 195-203.
29. Grady ED. Internal radiation therapy of hepatic cancer. Dis Colon Rectum. 1979;22:371-375.
30. Grady ED, McLaren J, Auda SP, et al. Combination of internal radiation therapy and hyperthermia to treat liver cancer. South Med J. 1983;76:1101-1105.
31. Gray B, van Hazel G, Buck M, et al. Treatment of colorectal liver metastases with SIR-Spheres plus chemotherapy. GI Cancer. 2000;3: 249-257.
32. Gray B, van Hazel G, Hope M, et al. Randomised trial of SIRSpheress plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol. 2001;12:1711-1720.
33. Gray BN, Burton MA, Kelleher DK, et al. Selective internal radiation (SIR) therapy for treatment of liver metastases: measurement of response rate. J Surg Oncol. 1989;42:192-196.
34. Gray BN, Anderson JE, Burton MA, et al. Regression of liver metastases following treatment with Yttrium-90 microspheres. Aust N Z J Surg. 1992;62:105-110.
35. Harbert JC, Ziessman HA. Therapy with intraarterial microspheres. Nucl Med Annu. 1987;8:295-319.
36. Herba MJ, Thirlwell MP. Radioembolization for hepatic metastases. Semin Oncol. 2002;29:152-159.
37. Herba MJ, Illescas FF, Thirlwell MP, et al. Hepatic malignancies: improved treatment with intraarterial Y-90. Radiology. 1988;169: 311-314.
38. Ho S, Lau WY, Leung TW, et al. Internal radiation therapy for patients with primary or metastatic hepatic cancer: a review. Cancer. 1998;83:1894-1907.
39. Houle S, Yip TK, Shepherd FA, et al. Hepatocellular carcinoma: pilot trial of treatment with Y-90 microspheres. Radiology. 1989;172: 857-860.
40. Ingold JA, Reed GB, Kaplan HS, et al. Radiation Hepatitis. Am J Roentgenol Radium Ther Nucl Med. 1965;93:200-208.
41. Jakobs TF, Hoffmann RT, Poepperl G, et al. Mid-term results in otherwise treatment refractory primary or secondary liver confined tumours treated with selective internal radiation therapy (SIRT) using 90Yttrium resin-microspheres. Eur Radiol. 2007;17: 1320-1330.
42. Jiao LR, Hansen PD, Havlik R, et al. Clinical short-term results of radiofrequency ablation in primary and secondary liver tumors. Am J Surg. 1999;177:303-306.
43. Jiao LR, Szyszko T, Al-Nahhas A, et al. Clinical and imaging experience with yttrium-90 microspheres in the management of unresectable liver tumours. Eur J Surg Oncol. 2007;33:597-602.
44. Kennedy AS, Coldwell D, Nutting C, et al. Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Int J Radiat Oncol Biol Phys. 2006;65: 412-425.
45. Kulik LM, Atassi B, van Holsbee L, et al. Yttrium-90 microspheres (TheraSpheres) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation. J Surg Oncol. 2006;94:572-586.
46. Landis SH, Murray T, Bolden S, et al. Cancer statistics, 1999. CA Cancer J Clin. 1999;49:8-31.
47. Lau WY, Leung WT, Ho S, et al. Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study. Br J Cancer. 1994;70:994-999.
48. Lau WY, Ho S, Leung TW, et al. Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres. Int J Radiat Oncol Biol Phys. 1998;40:583-592.
49. Lawrence TS, Robertson JM, Anscher MS, et al. Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys. 1995; 31:1237-1248.
50. Leung TW, Lau WY, Ho SK, et al. Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttriummicrospheres for inoperable hepatic tumors. Int J Radiat Oncol Biol Phys. 1995;33:919-924.
51. Lewandowski RJ, Thurston KG, Goin JE, et al. 90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging. J Vasc Interv Radiol. 2005;16:1641-1651.
52. Lim L, Gibbs P, Yip D, et al. Prospective study of treatment with selective internal radiation therapy spheres in patients with unresectable primary or secondary hepatic malignancies. Intern Med J. 2005;35:222-227.
53. Liu MD, Uaje MB, Al-ghazi MS, et al. Use of Yttrium-90 TheraSphere for the treatment of unresectable hepatocellular carcinoma. Am Surg. 2004;70:947-953.
54. Mancini R, Carpanese L, Sciuto R, et al. A multicentric phase II clinical trial on intra-arterial hepatic radiotherapy with 90yttrium SIR-spheres in unresectable, colorectal liver metastases refractory to i.v. chemotherapy: preliminary results on toxicity and response rates. In Vivo. 2006;20:711-714.
55. Mantravadi RV, Spigos DG, Tan WS, et al. Intraarterial yttrium 90 in the treatment of hepatic malignancy. Radiology. 1982;142: 783-786.
56. Marn CS, Andrews JC, Francis IR, et al. Hepatic parenchymal changes after intraarterial Y-90 therapy: CT findings. Radiology. 1993;187:125-128.
57. Morris D, Ross W, Iqbal J, et al. Cryoablation of hepatic malignancy: an evaluation of tumour marker data and survival in 110 patients. GI Cancer. 1996;1:247-251.
58. Murthy R, Nunez R, Szklaruk J, et al. Ytrrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. Radiographics. 2005;25: S41-S55.
59. Murthy R, Xiong H, Nunez R, et al. Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results. J Vasc Interv Radiol. 2005;16:937-945.
60. Nagorney DM, Gigot JF. Primary epithelial hepatic malignancies: etiology, epidemiology, and outcome after subtotal and total hepatic resection. Surg Oncol Clin N Am. 1996;5:283-300.
61. Patterson EJ, Scudamore CH, Owen DA, et al. Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size. Ann Surg. 1998;227:559-565.
62. Pö pperl G, Helmberger T, Munzing W, et al. Selective internal radiation therapy with SIR-Spheress in patients with nonresectable liver tumors. Cancer Biother Radiopharm. 2005;20:200-208.
63. Salem R, Lewandowski RJ, Atassi B, et al. Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival. J Vasc Interv Radiol. 2005;16:1627-1639.
64. Salem RS, Lewandowski R, Roberts C, et al. Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis. J Vasc Interv Radiol. 2004;15:335-345.
65. Sato K, Lewandowski RJ, Bui JT, et al. Treatment of unresectable primary and metastatic liver cancer with Yttrium-90 microspheres (TheraSpheres): assessment of hepatic arterial embolization. Cardiovasc Intervent Radiol. 2006;29:522-529.
66. Shepherd FA, Rotstein LE, Houle S, et al. A phase I dose escalation trial of yttrium-90 microspheres in the treatment of primary hepatocellular carcinoma. Cancer. 1992;70:2250-2254.
67. Stubbs RS, Wickremesekera SK. Selective internal radiation therapy (SIRT): a new modality for treating patients with colorectal liver metastases. HPB. 2004;6:133-139.
68. Stubbs RS, Alwan MH, Booth MW. Hepatic cryotherapy and subsequent hepatic arterial chemotherapy for colorectal metastases to the liver. HPB Surg. 1998;11:97-104.
69. Stubbs RS, Cannan RJ, Mitchell AW. Selective internal radiation therapy (SIRT) with 90Yttrium microspheres for extensive colorectal liver metastases. Hepatogastroenterology. 2001;48: 333-337.
70. Stubbs RS, Cannan RJ, Mitchell AW. Selective internal radiation therapy with 90yttrium microspheres for extensive colorectal liver metastases. J Gastrointest Surg. 2001;5:294-302.
71. Stubbs RS, O'Brien I, Correia MM. Selective internal radiation therapy with 90Y microspheres for colorectal liver metastases: single-centre experience with 100 patients. ANZ J Surg. 2006;76: 696-703.
72. Taylor I, Bennett R, Sherriff S. The blood supply of colorectal liver metastases. Br J Cancer. 1978;38:749-756.
73. Thamboo T, Tan KB, Wang SC, et al. Extra-hepatic embolisation of Y-90 microspheres from selective internal radiation therapy (SIRT) of the liver. Pathology. 2003;35:351-353.
74. Tian JH, Xu BX, Zhang JM, et al. Ultrasound guided internal radiotherapy using Yttrium-90-glass microspheres for liver malignancies. J Nucl Med. 1996;37:958-963.
75. Van Hazel G, Blackwell A, Anderson J, et al. Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol. 2004;88:78-85.
76. Vogl T, Mack MG, Straub R, et al. Percutaneous MRI-guided laserinduced thermotherapy for hepatic metastases for colorectal cancer. Lancet. 1997;350:29.
77. Weiss L, Grundmann E, Torhorst J, et al. Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol. 1986;150:195-203.
78. Wong CO, Salem R, Raman S, et al. Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI. Eur J Nucl Med. 2002;29:815-820.
79. Wong CO, Salem R, Qing F, et al. Metabolic response after intraarterial 90Y-glass microsphere treatment for colorectal liver metastases: comparison of quantitative and visual analyses by 18F-FDG PET. J Nucl Med. 2004;45:1892-1897.
80. Wong CO, Qing F, Savin M, et al. Reduction of metastatic load to liver after intraarterial hepatic Yttrium-90 radioembolization as evaluated by [18F]fluorodeoxyglucose positron emission tomographic imaging. J Vasc Interv Radiol. 2005;16:1101-1106.
81. Yan ZP, Lin G, Zhao HY, et al. An experimental study and clinical pilot trials on Yttrium-90 glass microspheres through the hepatic artery for treatment of primary liver cancer. Cancer. 1993;72: 3210-3215.